OsteoCentric Technologies, the inventor of UnifiMI, a breakthrough implant-to-bone interface technology that supports primary implant stability, is pleased to announce the addition of Jason E. Topolosky MBA, MTM/MSE as Chief Business Officer. With his wealth of M&A and strategy experience, Topolosky will focus on facilitating the widespread adoption of UnifiMI while raising the standard of care for implant-to-bone fixation.
In his new role, Topolosky will oversee corporate development activities, including forging strategic development partnerships, licensing, and acquisitions. He is set to bring over 22 years of corporate development and strategy experience that’s been proven to deliver above-segment revenue growth in highly competitive business markets. His global market entry and expansion, development of differentiated products and services, market intelligence, strategic planning, and portfolio analysis, buy-and-sell-side M&A, and operational integration experience adds significant value.
Having served as the global Vice President of Strategy &Portfolio Management at Olympus Corporation before joining OsteoCentric Technologies, Topolosky was pivotal in the strategic planning and portfolio management of ten Business Units. Prior to that, he spent 19 years at Stryker Corporation, during which he held the position of Vice President of Business Development & Strategy, Trauma &Extremities. During his tenure at Stryker, Jason played a vital role in the integration of Wright Medical following its $5.4B acquisition.
OsteoCentric Technologies CEO, Eric Brown, expressed excitement about welcoming Topolosky to the team, citing his experience and success in corporate development and strategy as instrumental for the organization’s strategic growth and partnership with leading orthopedic and dental companies. In response, Topolosky expressed his delight in joining OsteoCentric Technologies, expressing confidence in the revolutionary impact of the company’s core bone interface technology, UnifiMI, across all implants in the orthopedic, spine, dental, and veterinary segments.
OsteoCentric Technologies introduced UnifiMI Interface Technology as a game-changing method of instantly securing implants to bone. This innovative and minimally invasive technique addresses the problem of implant instability across orthopedic, spine, and dental surgical segments. With its headquarters in Austin, Texas, and an innovation and product development center in Logan, Utah, OsteoCentric Technologies is set to revolutionize implant-to-bone fixation.
This story was sourced from OsteoCentric Technologies.
Source link